Gilpin Wealth Management’s Core Laboratories CLB Stock Holding History

Gilpin Wealth Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-5	Closed	-$59	–	1435
2026 Q2	$59	Hold	5	–	–	﹤0.01%	1044
2026 Q1	$84	Hold	5	–	–	﹤0.01%	966
2025 Q4	$81	Buy	+5	New	+$74	﹤0.01%	870

Other funds holding CLB

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

HCA

Harpswell Capital Advisors Yarmouth, Maine $152M AUM 8.39% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Gilpin Wealth Management's CLB Position: Q3 2026 in Review

Gilpin Wealth Management sold out of Core Laboratories (CLB) in Q3 2026, closing a stake of 5 shares — an estimated $59 sold.

Gilpin Wealth Management first reported a position in CLB in Q4 2025 and held it in 3 quarters. The position peaked at $84 in Q1 2026. 4 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

Gilpin Wealth Management reported no remaining Core Laboratories position as of Q3 2026 after selling out during the quarter.
Gilpin Wealth Management sold 5 Core Laboratories shares in Q3 2026, an estimated $59.
Gilpin Wealth Management first reported a position in Core Laboratories in Q4 2025 and held it in 3 quarters.
Gilpin Wealth Management's Core Laboratories position peaked at $84 in Q1 2026.
4 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.